Achieving Long-Term Protection Post-MI
Panelists
Program Goals
Case Study 1
Case Study 1 (cont)
Case Study 1 (cont)
Safe to Stop DAPT?
Risk Scores From PARIS
Elective Surgery Timing in STEMI Patient With DES
Risk of MACE Following Noncardiac Surgery in Patients Post-PCI
Leading Risk Factors for MACE Post-Noncardiac Surgery in PCI Patients
Platelet Reactivity and Clinical Outcomes at 1-Year Follow-Up: ADAPT-DES
DES vs BMS 5 Study Meta-Analysis
ZEUS Trial
LEADERS FREE
Length of DAPT: STEMI Treated With DES US Perspective
Post-STEMI Treated With DES: Duration of DAPT European Perspective
Case Study 2
Case Study 2 (cont)
Case Study 2 (cont)
Euro Heart Survey: In-Hospital Use of Interventional Strategies for ACS
PLATO Cumulative Incidence of Primary Composite of CV Death, MI, and Stroke in Patients Intended for Noninvasive Management
TRILOGY ACS
CHARISMA
Markers of Increased Risk in Our Patient
Ischemic Risk and Efficacy of Ticagrelor in Relation to Time From P2Y12 Inhibitor Withdrawal
Bleeding Risk Score Patients With ACS
THEMIS
MATCH Outcomes
Calculation of a DAPT Score
PPIs
Cardiovascular OutcoMes for People Using Anticoagulation StrategieS
Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention (TWILIGHT)
GLOBAL LEADERS: A Clinical Study Comparing 2 Forms of Antiplatelet Therapy After Stent Implantation
Concluding Comments
Abbreviations
Abbreviations (cont)
Abbreviations (cont)